Home » Stocks » ILMN

Illumina, Inc. (ILMN)

Stock Price: $317.03 USD 13.05 (4.29%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 46.29B
Revenue (ttm) 3.24B
Net Income (ttm) 638.00M
Shares Out 146.00M
EPS (ttm) 4.31
PE Ratio 73.56
Forward PE 43.86
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $317.03
Previous Close $303.98
Change ($) 13.05
Change (%) 4.29%
Day's Open 305.00
Day's Range 304.01 - 319.33
Day's Volume 981,685
52-Week Range 196.78 - 404.20

More Stats

Market Cap 46.29B
Enterprise Value 44.81B
Earnings Date (est) Feb 2, 2021
Ex-Dividend Date n/a
Shares Outstanding 146.00M
Float 145.47M
EPS (basic) 4.34
EPS (diluted) 4.31
FCF / Share 6.39
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.36%
FCF Yield 2.02%
Payout Ratio n/a
Shares Short 4.06M
Short Ratio 3.58
Short % of Float 2.79%
Beta 1.11
PE Ratio 73.56
Forward PE 43.86
P/FCF Ratio 49.61
PS Ratio 14.29
PB Ratio 9.34
Revenue 3.24B
Operating Income 715.00M
Net Income 638.00M
Free Cash Flow 933.00M
Net Cash 1.47B
Net Cash / Share 10.09
Gross Margin 77.24%
Operating Margin 22.08%
Profit Margin 19.70%
FCF Margin 28.81%
ROA 7.12%
ROE 13.96%
ROIC 16.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (19)

Buy 3
Overweight 1
Hold 11
Underweight 1
Sell 3

Analyst Consensus: Hold

Price Target

$296.47*
(-6.49% downside)
Low
250
Current: $317.03
High
355
Target: 296.47
*Average 12-month price target from 15 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3,5433,3332,7522,3982,2201,8611,4211,1491,056903
Revenue Growth6.3%21.11%14.76%8.02%19.27%30.97%23.74%8.81%16.93%-
Gross Profit2,4672,3001,8261,6661,5491,298912774709602
Operating Income985883606587613515134201199212
Net Income1,00282672646346235312515186.63125
Shares Outstanding147147146147145136125123123124
Earnings Per Share6.745.564.923.073.102.370.901.130.620.87
EPS Growth21.22%13.01%60.26%-0.97%30.8%163.33%-20.35%82.26%-28.74%-
Operating Cash Flow1,0511,142875779786501386292358273
Capital Expenditures-209-296-312-271-143-142-90.56-81.01-79.55-56.47
Free Cash Flow842846563508643359296211279216
Cash & Equivalents3,4143,5122,1451,5591,3861,3381,1661,3501,190894
Total Debt1,8361,9971,1921,0581,0911,291869842807312
Net Cash / Debt1,5781,51595350129647.34297508382583
Assets7,3166,9595,2574,2813,6883,3403,0192,5662,1961,839
Liabilities2,7033,1142,5082,0111,8391,8771,4861,2481,121641
Book Value4,6133,7582,7492,1971,8491,4631,5331,3191,0751,198
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Illumina, Inc.
Country United States
Employees 7,700
CEO Francis A. deSouza

Stock Information

Ticker Symbol ILMN
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: ILMN
IPO Date July 28, 2000

Description

Illumina provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.